BridgeBio Pharma
BBIO
BBIO
116 hedge funds and large institutions have $3.82B invested in BridgeBio Pharma in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
22% more funds holding
Funds holding: 95 → 116 (+21)
17% more capital invested
Capital invested by funds: $3.28B → $3.82B (+$548M)
5.36% more ownership
Funds ownership: 91.29% → 96.65% (+5.4%)
Holders
116
Holding in Top 10
8
Calls
$25.4M
Puts
$743K
Top Buyers
| 1 | +$111M | |
| 2 | +$48M | |
| 3 | +$22.6M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$17.5M |
| 5 |
BlackRock
New York
|
+$11M |
Top Sellers
| 1 | -$77.9M | |
| 2 | -$11.7M | |
| 3 | -$9.73M | |
| 4 |
Millennium Management
New York
|
-$6.41M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$4.68M |